Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
about
Adapting Drug Approval Pathways for Bacteriophage-Based TherapeuticsPhage therapy of pulmonary infectionsBacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current statusBacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex.The search for therapeutic bacteriophages uncovers one new subfamily and two new genera of Pseudomonas-infecting Myoviridae.The Microbiome in Cystic Fibrosis.A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections.Phage Inhibit Pathogen Dissemination by Targeting Bacterial Migrants in a Chronic Infection Model.New drug developments in the management of cystic fibrosis lung disease.The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.Pseudomonas predators: understanding and exploiting phage-host interactions.Comparative transcriptomics analyses reveal the conservation of an ancestral infectious strategy in two bacteriophage genera.Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.Effect of Storage Temperature on the Stability of Spray Dried Bacteriophage Powders.Silk Route to the Acceptance and Re-Implementation of Bacteriophage Therapy-Part II.Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.Detection of Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of Cystic Fibrosis Patients.
P2860
Q26740597-9F9C8D05-0279-43F7-9206-90548F6175C5Q26781119-F6DCF385-2A04-4C98-8961-BB3180E4289FQ26799417-2374D469-B167-43D1-AE2F-58CD3B0FC374Q30390256-8B7EA887-7642-4BAF-95C3-1F04ABCD3C53Q35023371-CC8F62ED-1621-45D8-8A62-6985718817E2Q35917770-4851C849-E5FA-4A67-B94B-6E5E4102B476Q36052205-8D861D61-577B-4864-A370-AEBCE1A8A94AQ37737723-D170B63B-A609-41D8-812F-DB0CE5996EEBQ38790382-A28EEDA4-5B9C-47E8-B99E-CCB9DF078DA1Q39259998-9F24A124-0D9A-4F60-B921-40746F5B2697Q39397651-14554D47-A463-49EC-BB92-89532A353E19Q40204030-197F29B8-EEF9-40EA-90A0-EBE467BFD8FBQ40757720-F85ACD20-2DD9-4CE5-9688-75E701C585B1Q47097212-38500E3D-CFEE-4821-B190-D13620A24EF0Q51746957-128B4AE6-34B4-49C1-A5FF-D81F1C848CC4Q52431831-9726ABAE-2FB5-4B51-96A9-1486448F6B22Q54205022-9969218A-C184-41AB-8E97-3AAB8F5B9EB1Q55373289-99B2D9CC-A5AF-4A17-ADDF-ABE6CB9FD02A
P2860
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
@en
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
@nl
type
label
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
@en
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
@nl
prefLabel
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
@en
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
@nl
P2093
P50
P921
P356
P1476
Effectiveness of bacteriophages in the sputum of cystic fibrosis patients
@en
P2093
E Saussereau
N Molinari
P304
P356
10.1111/1469-0691.12712
P577
2014-07-26T00:00:00Z